Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Immunotherapy combination reduced the risk of death by 36 percent compared with chemotherapy alone.
Genetic test can help guide decisions about treatment after surgery.
Half of those treated with the experimental immunotherapy bb2121 no longer had detectable cancer.
Immunotherapy worked better than chemotherapy as first-line treatment for people with a favorable biomarker.
New drug targets RET mutations in multiple cancer types.
Yoga, meditation, acupuncture and more can be safely used to relieve side effects of standard treatment.
Using molecular tests to select the most appropriate treatment leads to better outcomes.
Fitness trackers predict how cancer patients will respond to treatment.
Taselisib and alpelisib improve progression-free survival, but side effects are a concern.
Those who received targeted therapy did equally well without kidney removal.
Immunotherapy combo leads to longer progression-free survival.
Twice as many patients were alive 18 months after starting treatment.
“These are the best outcomes reported to date in a Children’s Oncology Group trial for children with this cancer,” said the lead author.
‘Incredibly big change’ in treatment of deadly skin cancer, new data show
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.